Trending Topic

Stastical analysis indication diabetes mellitus .generative ai
5 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Saptarshi Bhattacharya, Sanjay Kalra, Lakshmi Nagendra

Very few trials in the history of medical science have altered the treatment landscape as profoundly as the UK Prospective Diabetes Study (UKPDS). Even 44 years after its inception, the trial and post-study follow-up findings continue to fascinate and enlighten the medical community. The study was conceived at a time when there was uncertainty about […]

Peter Ferenci, EASL ILC 2022: Wilson’s disease – diagnosis and treatment

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Aug 15th 2022

Wilson’s disease is a rare, genetic disorder characterized by the accumulation of excess copper in vital organs such as the liver and brain. Damage caused by the excess copper build-up can lead to symptoms of liver and neurological diseases. In this touchENDOCRINOLOGY interview, we speak with Prof. Peter Ferenci (Medical University of Vienna, Vienna, Austria) about the diagnosis and treatment of the condition. 

Questions

  1. Could you give us an overview of the clinical presentation and prognosis of Wilson’s disease? (0:17)
  2. What are the treatment options for Wilson’s disease and what factors should be considered when selecting treatments and doses? (1:50)
  3. How does fatty liver contribute to disease severity and progression in Wilson’s disease? (3:51)
  4. What have been the most important recent advances in the diagnosis of Wilson’s disease? (4:40)

Prof. Ferenci’s presentation entitled ‘Wilsons disease: update on diagnosis and treatment’ was given at the EASL ILC 2022, 22-26 June 

Disclosures: Prof. Peter Ferenci has acted as a consultant for Univar and Alexion.

Support: Interview supported by Touch Medical Media. Interview conducted by Gina Furnival.

Recorded as a highlight of EASL ILC 2022

Click here for more related content.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup